VeriMomIst n-prolyl palmitoyl tripeptide-56 acetate in der Schwangerschaft sicher?
No harmonised CLP reproductive classifications (ECHA Annex VI), no SCCS or CIR safety assessment flagging reproductive hazard, and no peer‑reviewed reproductive toxicity data identified (PubMed). As a peptide/lipopeptide there is no specific evidence of reproductive toxicity; therefore default hazard and mechanism scores are 0. Dermal absorption is expected to be low but measurable because of the palmitoyl lipophilic moiety, so exposure is scored low (e=1). Sources consulted: ECHA Annex VI, SCCS/CIR (no entries), PubMed (no reproductive studies), PubChem/CosIng (ingredient listing).
Pregnancy-safe products containing n-prolyl palmitoyl tripeptide-56 acetate
Related ingredients
Frequently asked questions
- Ist n-prolyl palmitoyl tripeptide-56 acetate in der Schwangerschaft sicher?
- No harmonised CLP reproductive classifications (ECHA Annex VI), no SCCS or CIR safety assessment flagging reproductive hazard, and no peer‑reviewed reproductive toxicity data identified (PubMed). As a peptide/lipopeptide there is no specific evidence of reproductive toxicity; therefore default hazard and mechanism scores are 0. Dermal absorption is expected to be low but measurable because of the palmitoyl lipophilic moiety, so exposure is scored low (e=1). Sources consulted: ECHA Annex VI, SCCS/CIR (no entries), PubMed (no reproductive studies), PubChem/CosIng (ingredient listing).
- Ist n-prolyl palmitoyl tripeptide-56 acetate während des Stillens sicher?
- Same rationale as pregnancy: no reproductive or lactation-specific hazard identified in authoritative sources. No evidence of transfer in milk; dermal exposure from cosmetics is expected to be low but measurable (e=1). Sources: ECHA Annex VI, SCCS/CIR (no entries), PubMed, PubChem/CosIng.
- Ist n-prolyl palmitoyl tripeptide-56 acetate sicher für Babyhaut?
- No infant‑specific hazard data located. Because the ingredient likely has low but measurable dermal absorption in adults (e=1) and infant skin has higher permeability and higher surface‑area‑to‑weight, exposure score is increased by +1 to e=2 for 0–3 year olds. No studies demonstrating infant toxicity were found. Sources: ECHA Annex VI, SCCS/CIR (no entries), PubMed, PubChem/CosIng.
- Wie bewertet VeriMom n-prolyl palmitoyl tripeptide-56 acetate?
- VeriMom bewertet n-prolyl palmitoyl tripeptide-56 acetate mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu n-prolyl palmitoyl tripeptide-56 acetate?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu n-prolyl palmitoyl tripeptide-56 acetate basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.